Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 21361 AL 21375

Coordination and redox properties of copper interaction with α-synuclein

Valensin D, Dell'Acqua S, Kozlowski H, Casella L.

J Inorg Biochem. 2016 Oct;163:292-300. doi: 10.1016/j.jinorgbio.2016.04.012. Epub 2016 Apr 11.

Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases

Van der Schyf CJ.

Drug Dev Res. 2016 Dec;77(8):458-468. doi: 10.1002/ddr.21368. Epub 2016 Nov 4.

Aging of cerebral white matter

Liu H, Yang Y, Xia Y, Zhu W, Leak RK, Wei Z, Wang J, Hu X.

Ageing Res Rev. 2017 Mar;34:64-76. doi: 10.1016/j.arr.2016.11.006. Epub 2016 Nov 16.

Comorbid conditions associated with Parkinson's disease: A longitudinal and comparative study with Alzheimer disease and control subjects

Santos García D, Suárez Castro E, Expósito I, de Deus T, Tuñas C, Aneiros A, López Fernández M, Núñez Arias D, Bermúdez Torres M.

J Neurol Sci. 2017 Feb 15;373:210-215. doi: 10.1016/j.jns.2016.12.046. Epub 2016 Dec 29.

The Role of Mitochondrial Aldehyde Dehydrogenase 2 (ALDH2) in Neuropathology and Neurodegeneration

Chen CH, Joshi AU, Mochly-Rosen D.

Acta Neurol Taiwan. 2016 Dec 15;25(4)(4):111-123.

Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis

Lyoo CH, Cho H, Choi JY, Hwang MS, Hong SK, Kim YJ, Ryu YH, Lee MS.

J Alzheimers Dis. 2016;51(3):671-5. doi: 10.3233/JAD-151052.

Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics

Belaidi AA, Bush AI.

J Neurochem. 2016 Oct;139 Suppl 1:179-197. doi: 10.1111/jnc.13425. Epub 2016 Feb 10.

The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease

Gadhave K, Bolshette N, Ahire A, Pardeshi R, Thakur K, Trandafir C, Istrate A, Ahmed S, Lahkar M, Muresanu DF, Balea M.

J Cell Mol Med. 2016 Jul;20(7):1392-407. doi: 10.1111/jcmm.12817. Epub 2016 Mar 29.

Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases

Forloni G, Artuso V, La Vitola P, Balducci C.

Mov Disord. 2016 Jun;31(6):771-81. doi: 10.1002/mds.26624. Epub 2016 Mar 31.

The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease

Clark LF, Kodadek T.

ACS Chem Neurosci. 2016 May 18;7(5):520-7. doi: 10.1021/acschemneuro.6b00042. Epub 2016 Apr 14.

Palmitoylation in Alzheimer's disease and other neurodegenerative diseases

Cho E, Park M.

Pharmacol Res. 2016 Sep;111:133-151. doi: 10.1016/j.phrs.2016.06.008. Epub 2016 Jun 9.

Endocannabinoid System in Neurological Disorders

Ranieri R, Laezza C, Bifulco M, Marasco D, Malfitano AM.

Recent Pat CNS Drug Discov. 2016;10(2):90-112. doi: 10.2174/1574889810999160719105433.

Protein Misfolding in Prion and Prion-Like Diseases: Reconsidering a Required Role for Protein Loss-of-Function

Leighton PL, Allison WT.

J Alzheimers Dis. 2016 Jul 6;54(1):3-29. doi: 10.3233/JAD-160361.

Mitochondrial Ca(2+) handling in Huntington's and Alzheimer's diseases - Role of ER-mitochondria crosstalk

Naia L, Ferreira IL, Ferreiro E, Rego AC.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):1069-1077. doi: 10.1016/j.bbrc.2016.07.122. Epub 2016 Jul 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias